Research Article

[Retracted] Analysis of the Clinical Efficacy of Azacytidine + Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia

Table 3

Hematology parameters ().

GroupnPLT (×109/L)Hb (g/L)WBC (×109/L)
BeforeAfterBeforeAfterBeforeAfter

Treatment group1071.23 ± 5.69239.45 ± 32.0590.45 ± 6.9874.29 ± 5.142.36 ± 0.295.71 ± 0.89
Control group1070.89 ± 7.02202.18 ± 20.3690.22 ± 7.0379.63 ± 3.202.41 ± 0.334.40 ± 0.78
T0.1193.1040.0732.7890.3603.500
0.9070.0060.9420.0120.7230.003